Avecho Biotechnology Limited (AVEFF)

Avecho Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	26	5	8	19	20	36
Market Cap Growth	341.01%	-35.15%	-59.65%	-6.44%	-44.02%	706.97%
Enterprise Value	22	2	6	17	17	34
Last Close Price	0.00	0.00	0.00	0.01	-	-
PS Ratio	28.79	7.00	23.42	24.41	34.71	120.55
PB Ratio	48.17	2.42	1.74	11.37	6.07	17.47
P/TBV Ratio	48.17	2.42	1.74	11.49	6.21	20.85
P/OCF Ratio	33.35	-	-	-	-	-
EV/Sales Ratio	22.35	2.85	17.81	21.69	28.84	114.07
Debt / Equity Ratio	0.07	0.33	0.03	0.10	0.02	0.06
Debt / FCF Ratio	0.05	-	-	-	-	-
Asset Turnover	0.21	0.18	0.09	0.26	0.19	0.09
Inventory Turnover	4.46	3.93	2.07	1.12	1.93	1.16
Quick Ratio	4.46	2.70	7.83	2.97	6.31	3.90
Current Ratio	4.62	2.81	8.31	3.83	6.91	4.46
Return on Equity (ROE)	-143.71%	-64.72%	-78.08%	-67.30%	-95.01%	-71.08%
Return on Assets (ROA)	-33.53%	-31.11%	-40.10%	-33.99%	-49.50%	-40.56%
Return on Capital Employed (ROCE)	-61.90%	-93.30%	-52.80%	-89.80%	-74.90%	-102.30%
Earnings Yield	-9.12%	-39.40%	-30.98%	-8.50%	-12.40%	-5.68%
FCF Yield	-	-50.09%	-28.67%	-6.23%	-11.99%	-3.08%
Buyback Yield / Dilution	-9.80%	-39.73%	-23.41%	-1.97%	-13.27%	-0.86%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.